High-strength self-healing capsule and production process thereof

US2024254057A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2024254057-A1
Application numberUS-202218017707-A
CountryUS
Kind codeA1
Filing dateJul 28, 2022
Priority dateDec 30, 2021
Publication dateAug 1, 2024
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided is a high-strength self-healing capsule and a supporting production process thereof, belongs to the field of self-healing of concrete, comprising: healing agent and maltose; further comprising: mixing cement, silica fume and expansive materials evenly to obtain healing agent powder; mixing the healing agent powder with maltose to obtain healing agent composite powder; pre-pressing the healing agent composite powder to form fine granules; sieving the fine granules made from the pre-pressing, and granulating to obtain capsule core granules; and spraying polyvinyl alcohol (PVA) solution to the capsule core granules, while blowing hot air to remove moisture on the surface of the capsule core granules, for the PVA solution to form a film on the surface of the capsule core granules, drying, and then obtaining. On the basis of the process of the present invention, according to the engineering service environment and use requirements of the cement-based materials, suitable healing agent raw materials can be selected and combined to efficiently produce capsules, so that they can play a targeted role in self-healing.

First claim

Opening claim text (preview).

1 . A high-strength self-healing capsule, comprising: healing agent and maltose; and, a method for preparing the high-strength self-healing capsule, comprising: mixing cement, silica fume and expansive materials evenly to obtain healing agent powder; mixing the healing agent powder with the maltose to obtain healing agent composite powder; pre-pressing the healing agent composite powder to form fine granules; sieving the fine granules made from the pre-pressing, and granulating to obtain capsule core granules; and spraying polyvinyl alcohol (PVA) solution to the capsule core granules, while blowing hot air to remove moisture on a surface of the capsule core granules, for the PVA solution to form a film on the surface of the capsule core granules, and then obtaining the high-strength self-healing capsule after drying. 2 . The high-strength self-healing capsule according to claim 1 , wherein an added amount of the maltose is 3-10% of a total mass of the healing agent powder. 3 . The high-strength self-healing capsule according to claim 1 , wherein the expansive material may be replaced with macromolecule water absorbing resin or expanded rubber powder. 4 . The high-strength self-healing capsule according to claim 1 , wherein a granule size of the capsule core granule is 1-5 mm. 5 . The high-strength self-healing capsule according to claim 1 , wherein conditions of the granulating are: a pressure degree is 30-60 kN, and a rotary speed is 10-40 r/min. 6 . The high-strength self-healing capsule according to claim 1 , wherein a pressure of the pre-pressing is 0-10 MPa. 7 . The high-strength self-healing capsule according to claim 1 , wherein a mesh diameter of a screen for sieving the fine granules is 0.12-0.18 mm. 8 . The high-strength self-healing capsule according to claim 1 , wherein a concentration of the PVA solution is 5-10%. 9 . The high-strength self-healing capsule according to claim 1 , wherein a temperature of the hot air is 40-70° C. 10 . The high-strength self-healing capsule according to claim 1 , wherein a condition of the drying is drying for 2-3 hours at 40-50° C. 11 . An application of the high-strength self-healing capsule of claim 1 in a self-healing of concrete.

Assignees

Inventors

Classifications

  • Chemical separation of ingredients, e.g. slowly soluble activator · CPC title

  • characterised by their processing, e.g. sequence of mixing the ingredients when preparing the premixtures · CPC title

  • Mortars activated by rain, percolating or sucked-up water; Self-healing mortars or concrete · CPC title

  • obtained by reactions only involving carbon-to-carbon unsaturated bonds · CPC title

  • C04B18/021Primary

    agglomerated by a mineral binder, e.g. cement · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2024254057A1 cover?
Provided is a high-strength self-healing capsule and a supporting production process thereof, belongs to the field of self-healing of concrete, comprising: healing agent and maltose; further comprising: mixing cement, silica fume and expansive materials evenly to obtain healing agent powder; mixing the healing agent powder with maltose to obtain healing agent composite powder; pre-pressing the …
Who is the assignee on this patent?
Univ Shandong
What technology area does this patent fall under?
Primary CPC classification C04B40/0046. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu Aug 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).